You are here: Industry Insights > X-Chem

News List

X-Chem and Excelra's GOSTAR Join Forces to Advance Drug Discovery for Challenging Targets prnasia
February 11, 2022
A new collaboration between data science and analytics leader, Excelra, and artificial intelligence pioneer X-Chem will accelerate preclinical drug discovery and aid scientists to find new drug candidates for currently hard-to-drug targets.
LEO Pharma and X-Chem Enter Into Discovery Research Agreement firstwordpharma
July 08, 2021
LEO Pharma A/S, a global leader in medical dermatology and X-Chem, Inc., the global leader in DNA-encoded library (DEL) driven discovery solutions, announced today that they have entered into a research collaboration and license agreement.
X-Chem Acquires IntelliSyn and AviSyn contractpharma
January 27, 2021
X-Chem, Inc., a provider of DNA-Encoded Library (DEL)-based discovery services, has acquired IntelliSyn, a Montreal-based drug discovery services company and its U.S.-based sister company, AviSyn.
Servier and X-Chem Enter Drug Discovery Collaboration contractpharma
January 08, 2021
Servier, a global pharmaceutical Group, and X-Chem Inc., a privately held drug discovery company, have partnered to identify and develop novel small molecules for the treatment of neurological disorders.
Almirall and X-Chem Announce Dermatology-Focused Drug Discovery Collaboration pharmafocusasia
December 13, 2018
X-Chem, Inc., a privately held biotechnology company applying its innovative drug discovery platform to the generation of novel small molecule therapeutics....
Otsuka, X-Chem Partner for Drug Discovery contractpharma
December 28, 2017
Otsuka Pharmaceutical and X-Chem announced that they have signed a collaborative research agreement to advance the discovery process for new Otsuka drug compounds.
Otsuka collaborates with X-Chem for new drug compounds biospectrumasia
December 27, 2017
X-Chem will utilize its DNA-encoded library (DEX) screening and informatics platform to search for novel drug leads for several Otsuka discovery targets.